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1. Introduction 
Clostridium perfringens type C strains that produce various toxins cause hemorrhagic noxious 
ulceration or mucousal necrosis of the small intestine in humans, pigs, cattle and chickens 
(Sakurai et al. 1997, Sakurai and Nagahama 2006). In humans, the bacteria cause necrotic 
enteritis, which is termed “pig-bel” (Sakurai and Nagahama 2006). C. perfringens has been 
classified into five types, A to E, according to the toxinogenicity of major extracellular toxins 
designated alpha-, beta-, epsilon- and iota-toxins. The C. perfringens strains defined as type C 
show alpha- and beta-, but not epsilon- and iota-toxigenicities (Sakurai and Nagahama 
2006). Type C strains produce alpha-toxin, beta-toxin, beta2-toxin, and perfringolysin O. 
Beta-toxin is known to be the primary pathogenic factor of necrotic enteritis in the type C 
strains (Tweten 2005, Sakurai and Nagahama 2006). Beta2-toxin is a toxin discovered in C. 
perfringens type C isolated from piglets with necrotic enteritis, and speculated to be 
important because its gene has been detected in most C. perfringens type C strains recovered 
from animals with clinical disease (Manteca et al. 2002, Waters et al. 2003).  
Most of the toxins produced by C. perfringens type C are toxic to particular cells or cell lines. 
Beta-toxin possesses lethal, dermonecrotic, and pressor activities. Direct evidence 
concerning the biological activities of beta-toxin had been lacking due to the absence of a 
susceptible cell line for experiments in vitro. However, a cell line that is susceptible to the 
toxin was found (Nagahama et al. 2003). The toxin induced swelling and lysis on HL60 cells 
by binding to lipid rafts and forming a functional oligomer. Beta2-toxins is lethal for mice 
and cytotoxic for the cell line I407 cells inducing cell rounding and lysis without affecting 
the actin cytoskeleton (Gibert et al. 1997). On the other hand, delta-toxin is toxic to various 
rabbit immune cells, i.e. alveolar macrophages, peritoneal appendix cells, bone marrow 
cells, splenocytes and thymocytes (Jolivet-Reynaud et al. 1982). Theta-toxin is the prototypic 
member of the cholesterol-dependent cytolysin (CDC) family that includes listeriolysin O 
(LLO), streptolysin O (SLO), pneumolysin, and others (Tweten 2005). Theta-toxin exhibits 
cytotoxic effects on macrophages to escape from phagosomes in consort with alpha-toxin. 
Alpha-toxin is essential for growth and spread of infection in the host (Sakurai et al. 2004), 
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and it helps C. perfringens avoid the host defense mechanism by altering the normal traffic of 
the host phagocytes (Ochi et al. 2002, Oda et al. 2006). The role played by alpha-toxin in 
pathogenesis is dictated by its ability to interact with membranes, whether from outside the 
cell or while inside the phagosomes (Naylor et al. 1998). Alpha-toxin possesses 
phospholipase C (PLC), sphingomyelinase (SMase) and biological activities causing 
hemolysis, lethality and dermonecrosis (Sakurai et al. 2004). On the other hand, enterotoxin, 
which has molecular masses of 35 kDa as a monomer (Duffy et al. 1982) and 90–200 kDa as 
aggregate forms with eukaryotic proteins (Singh et al. 2001), is known to be highly cytotoxic 
to Vero and Caco-2 cells (Gao and McClane 2012). Among the C. perfringens type C toxins 
reported previously, only enterotoxin is toxic to Vero cells, and no toxin is known to have a 
molecular mass of around 200 kDa without eukaryotic proteins. 
TpeL, a recently-described novel member of the family of large clostridial cytotoxins, was 
found in C. perfringens type C. TpeL (named TpeL: C. perfringens large cytotoxin) is a 
truncated homologue of Clostridium difficile TcdA and TcdB (Amimoto et al. 2007). TpeL was 
identified in the culture supernatant of C. perfringens strain CP4 and is thought to be 
associated with necrotic enteritis (Amimoto et al. 2007). Coursodon et al. (2012) reported 
that TpeL may potentiate the effect of other virulence attributes of necrotic enteritis caused 
by C. perfringens. 
2. The family of clostridial glucosylating toxins 
Cytosolic mono-O-glucosylation is an important molecular mechanism by which various 
bacterial protein toxins and effectors target eukaryotic cells. C. difficile TcdA and TcdB , 
Clostridium sordellii lethal toxin (TcsL) and Clostridium novyi alpha-toxin (TcnA) are 
important pathogenic factors of the family of large clostridial toxins (LCTs). The 
pathogenicity of C. difficile is based upon the action of at least one of the two major exotoxins 
(TcdA and TcdB) (Voth and Ballard 2005). TcdA and TcdB are the main cause of antibiotic-
associated diarrhea and pseudomembraneous colitis (Voth and Ballard 2005), as a 
consequence of treatment with antibiotics, which destroy the normal microflora of the gut 
and allow colonization and proliferation of C. difficile bacteria (Bartlett et al. 1977, Kelly and 
LaMont 2008). Although the precise pathogenic mechanisms of induction of diarrhea and 
colitis are not known, it is generally accepted that the toxin-induced glucosylation of Rho 
GTPases is central to the action of the C. difficile toxins (Kelly and LaMont 2008). TcsL is 
implicated in toxic shock syndrome after medical-induced abortion (Ho et al. 2009) and 
TcnA causes gas gangrene syndrome (Tsokos et al. 2008). All these toxins are 50 to 90% 
identical in their amino acid sequences. They are large proteins of 250 to 308 kDa. This 
family has now more than 30 members, including putative glycosyltransferases from C. 
perfringens, Escherichia coli, Citrobacter rodentium, Photobacterium profundum, Pseudomonas 
fluorescens and various species of Chlamydia and Chlamidophila.  
2.1. Structure of LCTs  
LCTs are single protein chains containing four functional domains and share 26 to 76 % 
sequence identity and are structurally and functionally organized (Busch and Aktories 
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2000). LCTs are composed of four domains, the glucosylating enzymatic A-domain, the 
autocatalytic processing C-domain, the translocating D-domain and the binding B-domain 
(Fig. 1). The one third C-terminal part exhibits multiple repeated sequences (31 short repeats 
and 7 long repeats in TcdA), which are involved in the recognition of a cell-surface receptor. 
A trisaccharide (Gal-α1-3Gal-β1-4GlcNac) has been found to be the motif recognized by 
TcdA. Related carbohydrates could be involved as TcdA receptor. The gp96, a member heat 
shock protein family, has been proposed to bind TcdA to the plasma membrane of 
enterocytes (Na et al. 2008). Because this B-domain exhibits sequence similarity to the 
carbohydrate binding region of the glucosyltransferase from Streptococcus mutans, it was 
suggested early on that this part of the toxin is involved in binding to a carbohydrate-
containing receptor. The crystal structure of the C-terminal binding domain of  
 
Figure 1. Domain organization of clostridial glucosylating toxins. 
Clostridial glucosylating toxins are composed of four domains, the glucosylating enzymatic 
domain (A-domain) , the autocatalytic processing domain (C-domain), the translocating 
domain (D-domain) and the binding domain (B-domain).  The A-domain has the 
glucosyltransferase activity. The B-domain containing polypeptide repeats is responsible for 
specific receptor-binding. The C-domain participates in the auto-catalytic cleavage of LCTs 
and is a cysteine-protease with the catalytic residues DHC. InsP6 is required for activation of 
the cysteine protease. The D-domain is likely involved in the delivery of the A-domain into 
the cytosol. This domain includes a hydrophobic region suggested to be important for 
insertion of the toxin into endosome membranes. 
TcdA has been determined (Ho et al. 2005, Greco et al. 2006), showing a solenoid-like 
structure with 32 repeats consisting of 15–21 amino acid residues and seven repeats 
consisting of 30 residues. The repeats form β-hairpins, arranged in pairs with each adjacent 
pair of hairpins rotated by 120° to the next pair, resulting in a screw-like structure of a left-
handed β-solenoid helix (Greco et al. 2006). Co-crystallization with a derivate of the 
trisaccharide α-Gal(1,3)β-Gal(1,4)βGlcNAc confirmed the carbohydrate binding capacity of 
the domain. In this complex there are two carbohydrate-binding regions. However, in the 
full-length C-terminal fragment there are seven of these potential binding domains that are 
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highly conserved, giving it a high binding capacity. Although there is little information 
about the binding domain of TcdB, it is believed that TcdB uses different receptors to bind to 
target cell surfaces than TcdA (Jank et al. 2007a).  
The cysteine protease C-domain is located between residues 543 and 769 in TcdA and 
between residues 543 and 767 in TcdB (Egerer et al. 2007, Giesemann et al. 2008). It was 
shown that cleavage of the toxin occurs auto-catalytically by a cysteine protease activity, 
which is harbored in the C-domain, covering residues 544–955, directly down-stream of the 
glucosyltransferase domain (Egerer et al. 2007, Giesemann et al. 2008). Cys-698 and His-653 
have been shown to be part of the catalytic dyad, which in addition to Asp-587 might 
participate in the auto-cleavage reaction (Egerer et al. 2007). The crystal structure of C-
domain (543–809) from TcdA was resolved in the presence of inositol hexakisphosphate 
(InsP6) (Pruitt et al. 2009). InsP6 binds to the C-Domain, causing a conformational change 
that activates the auto-catalytic activity (Egerer et al. 2009). This locates between the 
enzymatic A-domain and the delivery D-domain, playing a role in proteolytic cleavage of 
the toxin. The toxins undergo autoproteolysis allowing only the enzymatic A-domain to be 
released into the cytosol in the presence of InsP6. Once the target cell has taken up the LCT 
via receptor-mediated endocytosis at the B-domain, the toxin undergoes autoproteolysis in 
order to allow the A-domain to pass across the endosomal membrane into the cytosol 
(Kreimeyer et al. 2011).  
D-domain, which is located between residues 955 and 1852, is a large hydrophobic region 
that makes up almost 50% of the total size of the toxin (Barth et al. 2001, Qa'Dan et al. 2000). 
However, the exact function of D-domain is unknown. It is characterized by a hydrophobic 
stretch which is most probably responsible for membrane penetration (transmembrane 
prediction) (von Eichel-Streiber et al. 1992). Therefore, this region is speculated to as the 
translocation domain. Deletion studies proved the importance of the hydrophobic region for 
toxin activity (Barroso et al. 1994). A small region in the primary sequence between residues 
965 and 1128 is characterized by hydrophobic amino acids and is suggested to play a role in 
formation of transmembrane structure during pore formation and translocation of the toxin 
into the cytosol (Voth and Ballard 2005). Pore formation induced by the toxin has been 
shown in artificial lipid membranes (Barth et al. 2001, Giesemann et al. 2006). However, so 
far it is not clear how pore formation relates to the delivery of the toxin into the cytosol.  
The biologically active domain, A-domain, harboring the glucosyltransferase activity, is 
translocated into the cytosol, comprises the first 543 aa (Pfeifer et al. 2003, Rupnik et al. 
2005). Therefore, cleavage of the toxin is required. The 3D-structure of A-domain showed 
that it was closely related to other bacterial glucosyltransferases belonging to the 
glucosyltransferase A family (Reinert et al. 2005). The catalytic core consists of 234 aa and is 
formed by a mixed α/β-fold with mostly parallel β-strands as the central part. The more 
than 300 additional residues are mainly helices, of which the first four N-terminal helices are 
most probably involved in membrane association, therefore assuring close proximity of the 
enzyme with its substrates. The structure of the central core is similar to that of 
glucosyltransferase A family (Reinert et al. 2005, Ziegler et al. 2008). Characteristic for 
glucosyltransferase A family members is the DXD motif involved in complexation of 
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manganese ions, UDP and glucose. Mutation of these essential aspartate residues leads to 
inactivation of the toxin (Giesemann et al. 2008). The first aspartic residue of the DXD motif 
binds to ribosyl and glucosyl moieties of UDP-glucose and the second aspartic residues 
binds to divalent cation (mainly manganese ions) which increases the hydrolase activity 
and/or the binding of UDP-glucose (Just et al. 2000). Other amino acids in TcdB having an 
essential role in the enzymatic activity have been identified such as Trp-102 which is 
involved in the binding of UDP-glucose, Asp-270, Arg-273, Tyr-284, Asn-384, Trp-520, as 
well as Ile-383 and Glu-385 being important for the specific recognition of UDP-glucose 
(Busch et al 2000a and 2000b, Jank et al. 2005, Jank et al. 2007a,). Differences in α-helices 
probably account for the substrate specificity of each toxins (Reinert et al. 2005, Ziegler et al. 
2008). Chimeric molecules between TcdB and TcsL have been used to identify the sites of 
Rho-GTPase recognition. Amino acids 408 to 468 of TcdB ensure the specificity for Rho, Rac 
and Cdc42, whereas in TcsL, the recognition of Rac and Cdc42 is mediated by residues 364 
to 408, and that of Ras proteins by residues 408 to 516 (Voth and Ballard 2005, Jank et al. 
2007a). The four N-terminal helices which mediates the binding of TcsL to 
phosphatidylserine, are possibly involved in membrane interaction (Mesmin et al. 2004). 
Amino acids 22-27 of Rho and Ras GTPase which are part of the transition of the α1-helix to 
the swich 1 region, are the main domain recognized by the glucosylating toxins (Müller et 
al. 1999). The cosubstrate for the bacterial glucosyltransferases is UDP-glucose; only TcnA 
utilizes UDP-N-acetylglucosamine (UDP-GlcNAc) (Selzer et al. 1996). This difference in 
cosubstrate specificity is based on sterical hindrance by bulky amino acids (e.g. 
Ile383/Gln385 in TcdB) blocking the catalytic pocket for the larger UDP-GlcNAc. In TcnA, 
small serine and alanine residues at the corresponding positions allow UDP-GlcNAc to 
enter the catalytic cleft (Jank et al. 2005). Little is known so far about the 
molecular/structural determinants underlying the differences in substrate recognition by 
different glucosylating toxins.  
2.2. Internalization of LCTs  
LCTs enter eukaryotic target cells through receptor-mediated endocytosis according to the 
‘short trip model’ of bacterial exotoxin uptake (Sandvig et al. 2004). The cytotoxicity of the 
toxins are blocked by endosomal and lysosomal acidification inhibitors (monensin, 
bafilomycin A1, ammonium chloride) and the inhibiting effects can be by-passed by an 
extracellular acidic pulse (Popoff et al. 1996, Qa'Dan et al. 2000, Barth et al. 2001, Popoff and 
Bouvet 2009). As shown in Fig. 2, on binding to host cell receptors (Karlsson 1995, 
Giesemann et al. 2008), the toxins are endocytosed (Voth and Ballard 2005). After 
endocytosis, the acidification of early endosomes by the vesicular H+-ATPase induces a 
conformational change characterized by an increase in hydrophobicity, leading to 
membrane insertion (Qa'Dan et al. 2000, Barth et al. 2001, Voth and Ballard 2005). It reported 
that at low pH, LCTs induce channel formation in cell membranes and artificial lipid bilyers 
(Qa'Dan et al. 2000 and 2001, Giesemann et al. 2006). Membrane cholesterol seems critical for 
TcdA pore formation (Giesemann et al. 2006). Then, the hydrophobic region enables to form 
a pore through which the catalytic domain can translocate into the cytosol. Pore formation 
under acidic conditions has been demonstrated for TcdA and B (Barth et al. 2001, 
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Giesemann et al. 2006). The exact mode of translocation remains to determine. The 
translocation-ligand domain remains associated with endosomal membranes and only the 
catalytic-DXD domain penetrates into the cytosol (Pfeifer et al. 2003, Rupnik et al. 2005). The 
N-terminal catalytic domain (A-domain) is then delivered from the early endosomes into the 
cytosol by auto-proteolytic activity stimulated by InsP6 (Reineke et al. 2007, Egerer et al. 
2007). This autoproteolytic activity is induced by InsP6 and/or dithiothreitol and is 
responsible for the separation of the catalytic domain from the holotoxin (Egerer et al. 2007, 
Reineke et al. 2007). A cysteine protease domain (C-domain containing putative catalytic 
residues, DHC) has been identified close to the cutting site in TcdB (amino acid 544-955), 
which is conserved in all LCTs (Egerer et al. 2007, Reineke et al. 2007, Egerer et al. 2009). 
Cys-700, His-655 and Asp-589 have been identified as the catalytic triad. It reported that a 
cysteine protease catalytic triad is involved in processing of the toxin and auto-cleavage is 
essential for toxin activity (Egerer et al. 2007). Following its translocation and release, the 
catalytic-DXD fragment (A-domain) acts on its cytosolic targets, the GTPases of the Rho/Rac 
family, leading to the observed blockade of signal transduction processes and, consequently, 
the disaggregation of the cytoskeleton and cell death (Just and Gerhard 2004, Belyi and 
Aktories 2010). TcdA and B target Rho GTPases (Rho, Ras and Cdc42), which are molecular 
switches involved in numerous signal processes, in particular, the regulation of the actin 
cytoskeleton. Once the toxins enter the cytosol, they catalyse the addition of UDP-Glc (UDP-
glucose) to Thr-37 (monoglucosylation) in Rho GTPase leading to depolymerization of actin 
filaments, disruption of the cytoskeleton and eventually cell rounding and cell death (Jank et 
al. 2007b, Belyi and Aktories 2010) (Fig. 2). 
2.3. Glucosylation of Rho GTPase by LCTs 
In the cytosol, LCTs glucosylate small GTPases of the Rho and Ras superfamily (Popoff et al. 
1996, Selzer et al. 1996, Belyi and Aktories 2010). Small GTP-binding proteins involve 
organization of the cytoskeleton and control cellular activity of numerous other cellular 
enzymes. Rho proteins are molecular switches involved in various signal processes, 
including actin cytoskeleton regulation, cell cycle progression, gene transcription, and 
control of the activity of many enzymes like protein and lipid kinases, phospholipases, and 
nicotanimide adenine dinucleotide-oxidase (Etienne-Manneville and Hall 2002, Burridge 
and Wennerberg, 2004). In respect to their role in host–pathogen interactions, Rho proteins 
essentially participate in epithelial barrier functions and cell–cell contact, in immune cell  
LCTs bind with their B-domain to the receptor of target cells. After endocytosis, the toxin 
inserts into the endosome membrane most likely involving the hydrophobic part of the D-
domain. The acidic pH of the endosome triggers the first conformational change and results 
in pore formation of the ligand-translocation domain. Cytosolic InsP6 interacts with the 
cysteine protease C-domain and induces a second conformational change, activating the 
protease function. This results in cleavage of the toxin and release of the glucosyltransferase 
A-domain into the cytosol. In the cytosol, Rho GTPases are glucosylated and thereby 
inactivated. Inactive Rho can not interact with a numerous variety of effectors and induce 
multiple signaling events.  
 




Figure 2. Model of entry and intracellular modification of LCTs 
Migration, phagocytosis, cytokine production, wound repair, immune cell signaling, and 
superoxide anion production. Modification of small GTP-binding proteins by LCTs arises at 
a Thr-35/37, depending on the Rho GTPase isoforms (Fig. 3) (Belyi and Aktories 2010). 
Marked differences in substrate specificity have been recognized among the various LCTs. 
TcdA and B glucosylate Rho, Rac and Cdc42 at Thr-37, whereas TcsL glucosylates Ras at 
Thr-35, Rap, Ral and Rac at Thr-37 and TcsH glucosylates Rho, Rac, Cdc42 (Fig. 4). LCTs 
catalyze the glucosylation of 21 kDa small GTP-binding proteins from UDP-glucose, except 
TcnA which uses UDP-N-acetylglucosamine as cosubstrate. TcnA glucosylates Rho, Rac, 
Cdc42 (Fig. 4). LCTs cleave the cosubstrate and transfer the glucose moiety to the acceptor 
amino acid of the Rho proteins (Popoff et al. 1996, Popoff and Bouvet 2009, Belyi and 
Aktories 2010) (Fig. 3). The conserved Thr, which is glucosylated, is located in switch 1. Thr-
35/37 is involved in the coordination of Mg2+ and subsequently to the binding of the two 
phosphates of GTP. The hydroxyl group of Thr-35/37 is exposed to the surface of molecule 





Figure 3. Model of glucosyltransferase activity of LCTs. 
 
Figure 4. Protein substrates and cosubstrates of the LCTs. 
TcdA: Clostridium difficile toxin A, TcdB: Clostridium difficile toxin B, TcsL: Clostridium 
sordellii lethal toxin, TcsH: Clostridium sordellii hemorrhagic toxin, TcnA: Clostridium novyi 
alpha-toxin, TpeL: Clostridium perfringnes large cytotoxin. U-Glc: UDP-glucose, U-NAG: 
UDP-N-acetylglucosamine form, which is the only accessible substrate of LCTs. 
Glucosylation of Rho or Ras GTPases inhibits activation of the GTPases by GEFs and 
blocks interaction with their effectors (Sehr et al. 1998, Vetter et al. 2000) as well as the 
cycling of Rho GTPases between the membrane localization and cytosolic localization 
(Belyi and Aktories 2010). Glucosylated Rho proteins are located at the membrane. Most 
importantly, the toxin-induced glucosylation inhibits the active conformation of Rho/Ras 













Inac ve form Ac ve form 
OH 
 LCT MW(kDa) Sugar donor Protein substrate 
TcdA 308 U-Glc Rho, Cdc42, Rac1 
TcdB 270 U-Glc Rho, Cdc42, Rac1 
TcsL 271 U-Glc Rac1, H-Ras, Rap, Ral 
TcsH 300 U-Glc Rho, Rac,Cdc42 
TcnA 250 U-Glc, U-NAG Rho, Rac, Cdc42 
TpeL 191 U-Glc, U-NAG Rac1, H-Ras, Rap, Ral 
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prevents the recognition of the downstream effector, blocking the G-protein in the 
inactive form (Popoff and Bouvet 2009). 
2.4. Cellular effects of LCTs. 
The inactivation of Rho proteins by LCTs-induced glucosylation causes extensive 
morphological changes, with loss of actin stress fibers, reorganization of the cortical actin, 
disrupution of the intercellular junctions and thus increase in cell barrier permeability. 
The actin cytoskeleton of intoxicated cells is redistributed, causing shrinking and 
rounding up of most cell types, which is initially accompanied by the formation of 
neurite-like retraction fibers. Finally, the retraction fibers disappear and the cells detach 
from the dishes (Ottlinger and Lin 1988, Popoff and Bouvet 2009). Inactivation of Rac 
assumes to be critical player in disorganization of actin cytoskeleton (Halabi-Cabezon et 
al. 2008). Numerous other cellular responses to the inactivation of Rho and Ras proteins 
by LCTs have been described, which are all caused by inhibition of the various functions 
of the small GTPase. They include inhibition of secretion (Prepens et al. 1996), 
phospholipase D activity (Schmidt et al. 1996), apoptosis (Brito et al. 2002, Voth and 
Ballard 2005), chemoattractant receptor signaling (Servant et al. 2000), phagocytosis 
(Caron and Hall 1998) and alteration of endothelial barrier function (Hippenstiel et al. 
1997). However, the role of LCTs on pathogenesis including diarrhea and 
pseudomembranous colitis are still unknown.  
Tissue damage and inhibition of the barrier function of enterocytes might explain the fluid 
response in toxin-induced diarrhea. TcdA and B affect the morphology and function of tight 
junctions and associated proteins (ZO-1, ZO-2, occuludin, claudin) to decrease 
transepithelial resistance, whereas E-cadherin junctions show little alteration (Nusrat et al. 
2001, Chen et al. 2002, Aktories and Barbieri 2005). F-actin restruction is accompanied by the 
dissociation of occluding, ZO-1 and ZO-2 from lateral tight junctions without affecting 
adherens junctions. These data indicate that Rho proteins play an important role in tight 
junction regulation. On the other hand, TscH, which mainly modifies Rac, alter the 
permeability of intestinal cell monolayers causing a redistribution of E-cadherin whereas 
tight junctions are not significantly affected (Boehm et al. 2006).   
TcdA and B induce apoptosis as a consequence of Rho glucosylation and caspase 
activation (Nottrott et al. 2007, Gerhard et al. 2008) or possibly cell necrosis (Genth et al. 
2008). TcdB and TscH cause apoptosis by targeting mitochondria (Petit et al. 2003, 
Matarrese et al. 2007). In addition, the inactivation of Rho blocks various cellular 
functions including exocytosis, endocytosis, activation of lymphocyte, phagocytosis in 
macrophages, control of NADPH oxidase, activation of phospholipase D, contraction of 
smooth muscle, activation of the pro-apoptotic RhoB, and transcriptional activation via 
JNK/or p38 (Just and Gerhard 2004, Gerhard et al. 2005, Huelsenbeck et al. 2007, Popoff 
and Bouvet 2009). TcdA and B induce a large nflammatory response in the gut. There is 
massive infiltration of neutrophils, and release of many cytokines (Jefferson et al. 1999). 
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TcdA-caused p38 activation induces the production of IL-8 and IL-1beta, necrosis of 
monocytes, and inflammation of intestinal mucosa (Popoff and Bouvet 2009). TcsL 
glycocylates Ras and inhibits the MAP-kinase cascade and PLD regulation. On the other 
hand, the role of those inhibition on cytotoxicity is still unclear (Schmidt et al. 1998, El 
Hadj et al. 1999). 
3. Characterization of TpeL 
C. perfringens type C has been identified as a causative agent of necrotizing enterocolitis 
associated with diarrhea and dysentery in infant animals (Tweten 2005, Sakurai and 
Nagahama 2006). Type C strain produces various toxins responsible for the pathogenesis 
(Sakurai and Nagahama 2006). Amimoto et al. (2007) fractionated the culture filtrate of C. 
perfringens type C strain MC18, and they discovered an unknown toxin (TpeL) that was 
lethal to mice. The toxin was cytotoxic to Vero cells, and its molecular mass was estimated to 
be about 180 kDa by SDS-PAGE analysis (Amimoto et al. 2007). These characteristics 
completely differed from the previously reported toxins. TpeL was purified with HPLC and 
affinity column coupled with the mAb. Coursodon et al. (2012) reported that TpeL-
producing strains of C. perfringens type A are highly virulent for broiler chicks. Paredes-
Sabja et al. (2011) reported that TpeL is also expressed during sporulation and is a 
sporulation-regulated C. perfringens toxin. 
3.1. Toxicity of TpeL 
TpeL was lethal to mice and toxic to Vero cells (Amimoto et al. 2007). The lethal activity of 
the purified TpeL in mice was determined as 62 MLD/mg (one was 16 μg) and 91 LD50/mg 
(one LD50 was 11 μg) by intravenous injection (Amimoto et al. 2007). TpeL showed obvious 
cytotoxicity in Vero cells, and the specific activity was 6.2 x 105 CU/mg (one CU was 1.6 ng) 
(Amimoto et al. 2007). Morphological changes induced by TpeL in Vero cells. The cytopathic 
effect induced by a low dose of TpeL was characterized by the enlargement of cells and 
appearance of rounded cells. Vero cells treated with a high dose of TpeL initially manifested 
similar changes to those treated with the low dose, then formed aggregates, and eventually 
detached from the well surface (Amimoto et al. 2007).  
Vero cells were incubated with SLO (100 ng/ml) alone (A) or a combination of TpeL1-525 (10 
μg/ml) with SLO (100 ng/ml) (B) at 37 °C for 15 min. Pictures were taken after 120 min of 
resealing. (C) Vero cells were incubated with various amounts of TpeL1-525 with SLO (100 
ng/ml) at 37 °C for 15 min. After 120 min of resealing, pictures of cells were taken and the 
percentage of rounded cells was determined. Value of three experiments were given a mean 
± the standard deviation (SD). 
To clarify the biological acitivty of TpeL, we prepared a recombinant glycosyltransferase 
domain, TpeL1-525 (covering amino acids 1 to 525) because native TpeL is labile and is 
difficult to purify from the culture supernatant of C. perfringens type C, and the recombinant 
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full-length TpeL was poorly expressed in Escherichia coli (Nagahama et al. 2011). As TpeL1-
525 did not possess binding domain, we used the streptolysin O (SLO) delivery systems 
(Nagahama et al. 2011). As shown in Fig. 5(B), in the presence of SLO, TpeL1-525 caused the 
cell rounding like the native toxin. TpeL1-525 at 1 – 10 μg/ml in the presence of SLO induced 
cell rounding in a dose-dependent manner (Fig. 5(C)). The cells finally detached from the 
wells. On the other hands, the cells eventually detached from the well. Furthermore, when 
TpeL1-525 at a concentration of 1 to 10 μg/ml was delivered to the cells by SLO, cell viability 
decreased in a dose-dependent manner. The cytotoxicity was inhibited by the anti-TpeL 
antibody, and heat-inactivated TpeL1-525 was not cytotoxic. On the other hand, TpeL1-525 
by itself did not have the cytotoxic effects. The results indicated that the N-terminal region 
of TpeL plays a role in the cytotoxicity and the C-terminal region is responsible for the 
binding of cells. The morphological alteration of cultured cells induced by TpeL is similar to 
that caused by TcdB and TcsL.  
 
Figure 5. Morphological changes of Vero cells upon treatment with SLO plus TpeL1-525. 
3.2. tpeL gene 
The gene encoding TpeL revealed the presence an ORF of 4953 bases (Amimoto et al. 2007). 
The tpeL gene encoded 1651 amino acid residues and the molecular mass of TpeL calculated 
from the deduced amino acid sequence was 191 kDa. A signal peptide region was not found 
within the ORF. The deduced amino acid sequence shared homology with TcdA, TcdB, TcsL 
and TcnA, called LCTs. The homology scores were 39 % to TcdA, 38 % to TcdB, 39% to TcsL 
and 30% to TcnA. The amino acid sequence of TpeL is shorter than that of any of these 
toxins, and the homologous region was located at the N-terminal site of the LCTs. A DXD 
motif in N-terminal region of LCTs is essential for glycosyltransferase activity, and W-102 in 
TcsL is an essential amino acid residue for the enzyme activity (Busch et al. 2000a). TpeL 
conserved the DXD motif and W-102 of TcsL. However, the C-terminal carbohydrate-
binding sites of LCTs (von Eichel-Streiber et al. 1992) were not conserved.  
The tpeL gene was detected not only in type C strains isolated in recent years but also ATCC 
3626, a type B strain preserved for many years. It therefore suggest that the tpeL gene has 
been conserved in C. perfringens DNA for a long time. Interestingly, beta-toxin-gene-positive 
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(Amimoto et al. 2007). Complete chromosomal and plasmid sequences of C. perfringens type 
A strain 13 are available (Shimizu et al. 2002). Also, there is no tpeL gene sequence within the 
data. It has been pointed out that beta- and epsilon-toxin genes carried by plasmids are 
sometimes lost during the passage of the strains (Katayama et al. 1996, Gibert et al. 1997). So, 
when the strain loses the plasmids, it changes to type A. In genetic study, total DNAs were 
used in the cloning and detection of the tpeL gene (Amimoto et al. 2007). Sayeed et al. (2010) 
reported that tpeL gene is located approximately 3 kb downstream of the plasmid-borne cpb 
gene. Gurjar et al. (2010) also reported that tpeL gene is localized to the plasmids containing 
cpb gene of cpe-negative type C isolates.  
3.3. Glucosylation of small G proteins by TpeL 
Rac1 is the only substrate GTPase inactivated by all LCTs. When the cells were treated 
with TpeL in the presence of SLO, glycosylation of cellular Rac1 was confirmed by 
Western blotting with the glycosylation-sensitive anti-Rac1 (Mab102) (Genth et al. 2006, 
Nagahama et al. 2011). TpeL and TcsL (Voth and Ballard 2005) act on Rac1 and the Ras 
subfamily but not RhoA. Furthermore, the isomeric TcdB from the variant C. difficile 
serotype F strain 1470 (TcdBF) that glucosylates Rac1 but not RhoA, has a cytopathic 
effect (Jank et al. 2007b). Halabi-Cabezon et al. (2008) reported that the glucosylation of 
Rac1 rather than RhoA correlates with the cytopathic effect of TcdB. It has been reported 
that Rac1 plays a critical role in the organization of the actin cytoskeleton (Bosco et al. 
2009). These results strongly suggest that glycosylation of Rac1 is critical for the 
cytopathic effect of TpeL.   
TpeL uses UDP-Glc and UDP-GlcNAc as sugar donors (Nagahama et al. 2011). All other 
LCTs use a single UDP-hexose (Belyi and Aktories 2010). The crystal structure provides 
evidence that two amino acids in the vicinity of the catalytic cleft are responsible for the 
specificity (Jank et al. 2005). TcdA and B, which both use UDP-Glc, have isoleucine  
and glutamine in the equivalent positions (Ile-383 and Gln-385 in TcdB), whereas TcnL, 
which uses UDP-GlcNAc, has serine and alanine residues at the respective positions (Jank 
et al. 2005). It has been reported that the bulkier side chains of Ile-383 and Gln-385 in TcdB 
limit the space of the catalytic cleft for the binding of UDP-GlcNAc and the exchange of 
these side chains with smaller groups changes the cosubstrate specificity from UDP-Glc to 
UDP-GlcNAc (Jank et al. 2005). TpeL has the smaller side chain Ala-383 and the bulkier 
side chain Gln-385 at the respective positions (Amimoto et al. 2007). We speculate that 
Ala-383 and Gln-385 in TpeL may stabilize the binding of UDP-Glc and UDP- 
GlcNAc and favor the acceptance of UDP-Glc and UDP-GlcNAc as the cosubstrates  
(Nagahama et al. 2011).  
The sequential glycosylation of Rac1 by TpeL followed by TcdB, and vice versa indicates 
that both toxins share the same acceptor amino acid in Rac1. The acceptor amino acid of 
TcdB-glycosylated Rac1 has been determined as Thr-35 (Belyi and Aktories 2010). TpeL 
inactivates Rac1 through the glycosylation of Thr-35 (Nagahama et al. 2011). 
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TpeL glycosylated Rac1, as well as the Ras subfamily consisting of Ha-Ras, RalA, and 
Rap1B, but not RhoA and Cdc42 (Fig. 4). Important differences in substrate specificity have 
been detected among the various LCTs. Whereas TcdA, TcdB, and TcnA modify most RhoA, 
Rac1, and Cdc42 isoforms, TcsL glucosylates Rac1 but not RhoA or Cdc42 (Voth and Ballard 
2005). On the other hand, TcsL also modifies the Ras subfamily, including Ras, Rap, and Ral 
isoforms (Voth and Ballard 2005). Thus, TpeL modifies similar substrates to TcsL. It was 
reported that Arg-455, Asp-461, Lys-463, and Glu-472 and residues of helix α17 (e.g., Glu-
449) of TcdB are essential for enzyme-RhoA recognition (Jank et al. 2007b). Changing the 
respective amino acid residues in TcsL to those of TcdB reduced glycosylation of Ras by 
TcsL (Jank et al. 2007a). Furthermore, the introduction of helix α17 of TcdB into TcsL caused 
a reduction in the glycosylation of Ras subfamily proteins but permitted the glycosylation of 
RhoA, indicating that helix α17 is involved in RhoA's recognition by TcdB (Jank et al. 
2007b). Glu-449, Lys-463, and Glu-472 in TcdB correspond to Lys, Arg, and Gly residues in 
TcsL and TpeL. Arg-455 in TcdB corresponds to Lys in TcsL and Gly in TpeL (Amimoto et 
al. 2007). The difference in those amino acid residues may be involved in recognizing small 
GTPases by TpeL. Additional residues in LCTs are needed for the recognition of small 
GTPases. 
4. Conclusion  
Infection with TpeL-positive C. perfringens strains may yield disease with a more rapid 
course and higher case fatality rate in broiler chicks. Thus, TpeL may potentiate the effect of 
other virulence attributes of necrotic enteritis strains of C. perfringens. TpeL from C. 
perfringens has been identified as a glycosyltransferase using UDP-GlcNAc and UDP-Glc as 
cosubstrates. The substrates of TpeL are confined to Rac1 and Ras subfamily proteins. The 
modification of Thr-35 on Rac1 induces cytopathic effects. 
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